These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. No evidence of aberrant amyloid β and phosphorylated tau expression in herpes simplex virus-infected neurons of the trigeminal ganglia and brain. Tran DN; Bakx ATCM; van Dis V; Aronica E; Verdijk RM; Ouwendijk WJD Brain Pathol; 2022 Jul; 32(4):e13044. PubMed ID: 34913212 [TBL] [Abstract][Full Text] [Related]
6. On the prevention and treatment of Alzheimer's disease: Control the promoters and look beyond the brain. Goldstein MR; Cheslock M Med Hypotheses; 2021 Sep; 154():110645. PubMed ID: 34315048 [TBL] [Abstract][Full Text] [Related]
7. β-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1. Bourgade K; Garneau H; Giroux G; Le Page AY; Bocti C; Dupuis G; Frost EH; Fülöp T Biogerontology; 2015 Feb; 16(1):85-98. PubMed ID: 25376108 [TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction. Carter CJ Neurochem Int; 2011 Feb; 58(3):301-20. PubMed ID: 21167244 [TBL] [Abstract][Full Text] [Related]
9. Persistent Infection with Herpes Simplex Virus 1 and Alzheimer's Disease-A Call to Study How Variability in Both Virus and Host may Impact Disease. Mangold CA; Szpara ML Viruses; 2019 Oct; 11(10):. PubMed ID: 31635156 [TBL] [Abstract][Full Text] [Related]
10. The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1. Wozniak MA; Frost AL; Itzhaki RF Antiviral Res; 2013 Sep; 99(3):401-4. PubMed ID: 23867133 [TBL] [Abstract][Full Text] [Related]
11. Cerebral Organoids for Modeling of HSV-1-Induced-Amyloid β Associated Neuropathology and Phenotypic Rescue. Qiao H; Zhao W; Guo M; Zhu L; Chen T; Wang J; Xu X; Zhang Z; Wu Y; Chen P Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682661 [TBL] [Abstract][Full Text] [Related]
12. Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease. Harris SA; Harris EA J Alzheimers Dis; 2015; 48(2):319-53. PubMed ID: 26401998 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection. Eimer WA; Vijaya Kumar DK; Navalpur Shanmugam NK; Rodriguez AS; Mitchell T; Washicosky KJ; György B; Breakefield XO; Tanzi RE; Moir RD Neuron; 2018 Jul; 99(1):56-63.e3. PubMed ID: 30001512 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the effects of herpes simplex glycoprotein B on complement system and cytokines in in vitro models of Alzheimer's disease. Yirün A; Çakır DA; Sanajou S; Erdemli Köse SB; Özyurt AB; Zeybek D; Bozdemir Ö; Baydar T; Erkekoglu P J Appl Toxicol; 2023 Sep; 43(9):1368-1378. PubMed ID: 36999203 [TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. Wozniak MA; Mee AP; Itzhaki RF J Pathol; 2009 Jan; 217(1):131-8. PubMed ID: 18973185 [TBL] [Abstract][Full Text] [Related]
18. Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer's disease. Sakakibara Y; Sekiya M; Saito T; Saido TC; Iijima KM BMC Neurosci; 2019 Mar; 20(1):13. PubMed ID: 30894120 [TBL] [Abstract][Full Text] [Related]
19. Herpes simplex virus type 1 and Alzheimer's disease: the autophagy connection. Itzhaki RF; Cosby SL; Wozniak MA J Neurovirol; 2008 Jan; 14(1):1-4. PubMed ID: 18300070 [TBL] [Abstract][Full Text] [Related]
20. Anti-Viral Agents in Neurodegenerative Disorders: New Paradigm for Targeting Alzheimer's Disease. Faldu KG; Shah JS; Patel SS Recent Pat Antiinfect Drug Discov; 2015; 10(2):76-83. PubMed ID: 25963683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]